Share via Email

 
* Email To:      (Separate multiple addresses with a semicolon)
* Email From:    (Your IP Address is 54.198.68.152 )
* Email Subject:    (personalize your message)
* Required:  
ID=419  
Email Body:   
 

FDA Report on Antibiotic Sales

  

Nov 21, 2011

The FDA has published a report on antibiotic sales for 2010.  The document was finalized on October 31st 2011 and contains updates and corrections to the previous incorrect version.

In accordance with Section 105 of the Animal Drug User Fee Amendment Act of 2008 and amended Section 512 of the Federal Food Drug and Cosmetic Act, manufacturers of antibiotics are required to submit annual reports to the FDA documenting the amounts of each ingredient sold, distributed or exported for use in food producing animals.  The summary report does not delineate each class of antibiotic as to species.

  

Almost all (97.5%) of the 18,775 ton total, including all classes of antibiotics manufactured in 2010 in the U.S. was administered to U.S. flocks and herds. The total manufactured in 2010 is approximately 1.3% higher than in 2009.

It is noted that the ionophores classed as antibiotics by the FDA, representing 22% of total production, are used to prevent coccidiosis.

The principal classes of antibiotics manufactured are listed below:-

Antibiotic Classes Manufactured in the U.S. for Livestock in 2010

Class Tons
Tetracyclines 6,151
Ionophores 4,203
Penicillins 1,916
Macrolides 1,217
Sulfas 1,114
*NIR 3,338
Other 836
Total 18,755

*Not independently reported, includes streptogramins, polypeptides & fluoroquinolones